Comparative analysis of REGγ expression in mouse and human tissues

Journal of Molecular Cell Biology

Volumn 2, Issue 4, 2010, Pages 192-198

  Yu, Guowu ^a,b   Zhao, Yanyan ^a   He, Jing ^a   Lonard, David M ^c   Mao, Chai An ^d   Wang, Guangqiang ^a   Li, Mingyang ^b   Li, Xiaotao ^c  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SOUTHWEST UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell; Expression; Reg ; Tissue

Indexed keywords

AUTOANTIGEN; KI ANTIGEN; PROTEASOME;

ANIMAL; ANIMAL ANATOMY; ARTICLE; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; MOUSE MUTANT; TESTIS;

ANIMAL STRUCTURES; ANIMALS; AUTOANTIGENS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICE; MICE, KNOCKOUT; PROTEASOME ENDOPEPTIDASE COMPLEX; TESTIS;

EID: 78049438319     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjq009     Document Type: Article

References (21)

1. Barton, L. F., Runnels, H. A., Schell, T. D., Cho, Y., Gibbons, R., Tevethia, S. S., Deepe, G. S., Jr., and Monaco, J. J. (2004). Immune defects in 28-kDa proteasome activator gamma-deficient mice. J. Immunol. 172, 3948-3954. (Pubitemid 38337983)
2. Bett, J. S., Goellner, G. M., Woodman, B., Pratt, G., Rechsteiner, M., and Bates, G. P. (2006). Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target. Hum. Mol. Genet. 15, 33-44. (Pubitemid 43020102)
3. Chen, X., Barton, L. F., Chi, Y., Clurman, B. E., and Roberts, J. M. (2007). Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol. Cell 26, 843-852. (Pubitemid 46921008)
4. DeMartino, G. N., and Gillette, T. G. (2007). Proteasomes, machines for all reasons. Cell 18, 659-662.
5. Dubiel, W., Pratt, G., Ferrell, K., and Rechsteiner, M. (1992). Purification of an 11 S regulator of the multicatalytic protease. J. Biol. Chem. 267, 22369-22377.
6. Goellner, G. M., and Rechsteiner, M. (2003). Are Huntington's and polyglutamine-based ataxias proteasome storage diseases? Int. J. Biochem. Cell Biol. 35, 562-571. (Pubitemid 36372072)
7. Khor, B., Bredemeyer, A. L., Huang, C. Y., Turnbull, I. R., Evans, R., Maggi, L. B., Jr., White, J. M., Walker, L. M., Carnes, K., Hess, R. A., et al. (2006). Proteasome activator PA200 is required for normal spermatogenesis. Mol. Cell Biol. 26, 2999-3007.
8. Li, Z., Jansen, M., Pierre, S. R., and Figueiredo-Pereira, M. E. (2003). Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation. Int. J. Biochem. Cell Biol. 35, 547-552. (Pubitemid 36369504)
9. Li, X., Amazit, L., Long, W., Lonard, D. M., Monaco, J. J., and O'Malley, B. W. (2007). Ubiquitin-and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol. Cell 26, 831-842. (Pubitemid 46921009)
10. Ma, C. P., Slaughter, C. A., and DeMartino, G. N. (1992). Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J. Biol. Chem. 267, 10515-10523.
11. Mao, I., Liu, J., Li, X., and Luo, H. (2008). REGgamma, a proteasome activator and beyond? Cell Mol. Life Sci. 65, 3971-3980.
12. Masson, P., Andersson, O., Petersen, U. M., and Young, P. (2001). Identification and characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S REGgamma (PA28gamma). J. Biol. Chem. 276, 1383-1390. (Pubitemid 32096569)
13. Murata, S., Kawahara, H., Tohma, S., Yamamoto, K., Kasahara, M., Nabeshima, Y., Tanaka, K., and Chiba, T. (1999). Growth retardation in mice lacking the proteasome activator PA28gamma. J. Biol. Chem. 274, 38211-38215. (Pubitemid 30026896)
14. Noda, C., Tanahashi, N., Shimbara, N., Hendil, K. B., and Tanaka, K. (2000). Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats. Biochem. Biophys. Res. Commun. 277, 348-354.
15. Rechsteiner, M., and Hill, C. P. (2005). Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol. 15, 27-33. (Pubitemid 40094678)
16. Roessler, M., Rollinger, W., Mantovani-Endl, L., Hagmann, M. L., Palme, S., Berndt, P., Engel, A. M., Pfeffer, M., Karl, J., Bodenmuller, H., et al. (2006). Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol. Cell Proteomics 5, 2092-2101. (Pubitemid 44817021)
17. Sean, D., and Meltzer, P. S. (2007). GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 23, 1846-1847. (Pubitemid 47250323)
18. Smyth, G. K. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3 (article 3).
19. Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004). A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101, 6062-6067. (Pubitemid 38520528)
20. Ustrell, V., Hoffman, L., Pratt, G., and Rechsteiner, M. (2002). PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21, 3516-3525. (Pubitemid 34760581)
21. Zhang, Z., and Zhang, R. (2008). Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J. 27, 852-864. (Pubitemid 351417171)